Table 3. Suggested frequency of monitoring during and after antiviral therapy.
Serum marker | On therapy | After therapy |
---|---|---|
HBV DNA | Every 12 weeks (every 24 weeks after one year) | Every 4 to12 weeks (every 24 to 48 weeks after one year) |
HBeAg, anti-HBe | Every 24 weeks (If HBeAg positive) | Every 4 to 12 weeks (every 24 to 48 weeks after one year) |
HBsAg | Every 24 to 48 weeks (If HBeAg negative) | Every 48 weeks |
ALT | Every 12 weeks | Every 12 weeks |
Liver biopsy | Not Needed | Individualized |
Creatinine/Phosphate (ADV/TDF) | Every 12 weeks | Not needed |
CBC (Interferon) | Every 4 weeks | Not Needed |
TSH (Interferon) | Every 12 weeks | Not needed |
Abbreviations: ADV, adefovir; TDF, tenofovir; CBC, complete blood count; TSH, thyroid stimulating hormone